Clinical trial
Retrospective Study of the Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients With Moderate to Severe Impairment Without Objective of Resuscitation Management (Level of Care 3 and 4) at the Hospices Civils of Lyon
NCT04522037 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of the Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients With Moderate to Severe Impairment Without Objective of Resuscitation Management (Level of Care 3 and 4) at the Hospices Civils of Lyon
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2020
- Completion date
- February 28, 2021
- Enrollment
- 200 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 disease, moderate to severe dyspnea, patients hospitalized in the hospices civils of lyon, without resuscitation objective management